Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Covidien plc    COV   IE00B68SQD29


SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Covidien plc : Covidien Recalls Duet TRS Staplers on Anatomical Injury Potential

08/22/2012 | 09:55am US/Eastern
   By Saabira Chaudhuri 

Covidien PLC (COV) is voluntarily recalling its Duet TRS staplers after receiving one report that links the tissue reinforcement material to a post-operative injury after abdominal surgery.

Launched in 2009, the product is a tissue reinforcement system to support staple lines. To date, Covidien has sold more than 540,000 worldwide.

Covidien on Wednesday said it has stopped manufacturing the units, after concluding that Duet TRS may have the potential to injure adjacent anatomical structures, which may result in life threatening post-operative complications.

The affected product codes range between 4535 to 6048A.

The most recent recall is in addition to one unveiled in January relating to the contraindication of the device in the thoracic cavity. At that time, Covidien received reports of 13 serious injuries and three fatalities following the application of Duet TRS in the thoracic cavity.

On Wednesday, the company said all Duet TRS products can be returned by emailing or calling 1-800-722-8772, option 1, to obtain a return goods authorization prior to returning the affected units.

People can report adverse events or quality problems related to the product by calling or emailing the Food and Drug Administration's MedWatch Adverse Event Reporting program.

Write to Saabira Chaudhuri at

Subscribe to WSJ:

Recommend :
React to this article
Latest news on COVIDIEN PLC
6h ago COVIDIEN : Survey Shows 43 Percent of Americans Ages 40 and Older Have Experienc..
5d ago COVIDIEN : to Report Fourth-Quarter and Fiscal 2014 Results on November 5, 2014
6d ago COVIDIEN : Announcement under Irish Takeover Rules Relevant Securities in Issue ..
7d ago New U.S. tax rules chill 'inversion' deal-making; shares dive
7d ago Pending 'inversions' that new U.S. Treasury rules may hit
7d agoDJCovidien Files 8K - Changes Executive Management
09/23 AstraZeneca, Shire dive as U.S. tax move punctures deal hopes
09/23 AstraZeneca, Shire dive as U.S. tax move punctures deal hopes
09/23 U.S. Treasury moves against tax-avoidance 'inversion' deals
09/18DJU.S. HOT STOCKS : Hot Stocks to Watch
Duration : Period :
Covidien plc Technical Analysis Chart | COV | IE00B68SQD29 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes